Rapid Micro Biosystems (RPID) Total Current Liabilities (2020 - 2026)

Rapid Micro Biosystems has disclosed Total Current Liabilities across 7 years of filings, most recently posting $19.1 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $19.1 million, up 27.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.1 million (up 27.49% YoY), and the FY2025 annual result was $18.5 million, up 5.25% from the prior year.
• Total Current Liabilities came in at $19.1 million for Q1 2026 at Rapid Micro Biosystems, up from $18.5 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $19.1 million in Q1 2026 to a low of $12.8 million in Q2 2022.
• The 5-year median for Total Current Liabilities is $15.9 million (2024), against an average of $16.2 million.
• Across the five-year window, Total Current Liabilities decreased 20.34% in 2022 and increased 27.49% in 2026, its largest moves.
• Rapid Micro Biosystems' Total Current Liabilities stood at $19.0 million in 2022, then slipped by 0.34% to $19.0 million in 2023, then retreated by 7.48% to $17.6 million in 2024, then rose by 5.25% to $18.5 million in 2025, then climbed by 3.42% to $19.1 million in 2026.
• The last three Total Current Liabilities figures came in at $19.1 million (Q1 2026), $18.5 million (Q4 2025), and $16.5 million (Q3 2025), per Business Quant data.